Author:
Bartels S,Faisal M,Büsche G,Schlue J,Kreipe H,Lehmann U
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference13 articles.
1. Passamonti F, Giorgino T, Mora B, Guglielmelli P, Rumi E, Maffioli M et al. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis. Leukemia 2017; e-pub ahead of print 31 May 2017 doi:10.1038/leu.2017.169.
2. Tefferi A, Barbui T . Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 2017; 92: 94–108.
3. Cerquozzi S, Tefferi A . Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J 2015; 5: e366.
4. Arber D, Orazi A, Hasserjian R, Thiele J, Borowitz M, Le Beau M et al. The 2016 revision of the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391–2405.
5. Chen P, Ouyang J, Liang J, Yu X, Huang B . Study on the Clinical Significance of JAK2V617F Allele Burden in Philadelphia Chromosome-Negative Myeloproliferative Neoplasm. Clin Lab 2016; 62: 1477–1481.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献